Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

INBX stock hub

Inhibrx Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INBXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INBX

In the news

Latest news · INBX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-197.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-65.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INBX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001739614
Company name	Inhibrx Biosciences, Inc.
Country	United States
Country code	US
Cusip	45720L107
Employees	110
Employees Change	-51%
Employees Change Percent	-31.68
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-08-19
Isin	US45720N1037
Last refreshed	2026-05-10
Market cap	$2B
Market cap category	Small-Cap
Price	$134
Price currency	USD
Rev Per Employee	11,818.18x
Sector	Healthcare
Sic	2836
Symbol	INBX
Website	https://inhibrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.14%
EV/Sales	1,496.37x
FCF yield	-6.62%
P/B ratio	245.03x
P/S ratio	1,509.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-111.7M
Net Income	$-140.1M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-10,773.31%
Profit Per Employee	$-1.3M
ROA	-51.58
Roa5y	-62.33
ROCE	-119.8
ROE	-197.8
Roe5y	-52.96
ROIC	-65.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,112.43%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	550x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$146.5M
Cash	$124.2M
Current Assets	$132.8M
Current Liabilities	$33.8M
Debt	$107M
Debt Equity	$13.39
Equity	$8M
Interest Coverage	-11.07
Liabilities	$138.5M
Long Term Assets	$13.6M
Long Term Liabilities	$104.7M
Net Cash	$17.2M
Net Cash By Market Cap	$0.88
Net Cash Growth	-88.1%
Net Debt Equity	$-2.15
Tangible Book Value	$8M
Tangible Book Value Per Share	$0.55
WACC	24.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.93
Inventory Turnover	58.29
Net Working Capital	$-22.9M
Quick ratio	3.68
Working Capital	$99M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.36%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,110.36%
200-day SMA	64.25
50-day SMA	85.94
50-day SMA vs 200-day SMA	50over200
All Time High	155.3
All Time High Change	-13.48%
All Time High Date	2026-04-22
All Time Low	10.8
All Time Low Change	1,143.98%
All Time Low Date	2024-08-12
ATR	11.04
Beta	3.89
Beta1y	2.15
Beta2y	1.19
Ch YTD	70.06
High	134.9
High52	155.3
High52 Date	2026-04-22
High52ch	-13.48%
Low	121.4
Low52	10.84
Low52 Date	2025-05-14
Low52ch	1,139.39%
Ma50ch	56.33%
Price vs 200-day SMA	109.12%
RSI	67.14
RSI Monthly	86.99
RSI Weekly	77.94
Sharpe ratio	2.4x
Sortino ratio	7.14
Tr YTD	70.06
Tr1m	115.48%
Tr1w	4.32%
Tr3m	60.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Buy
Earnings EPS Estimate	$-1.43
Operating Income	$-135M
Operating margin	-10,386.5
Price target	$150
Price Target Change	$11.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,805,594%
Float Percent	53.44%
Net Borrowing	99,965,000
Shares Insiders	18.85%
Shares Institutions	61.2%
Shares Out	14,607,286
Shares Qo Q	0.36%
Shares Yo Y	3.36%
Short Float	27.38%
Short Ratio	8.56
Short Shares	14.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-141M
Average Volume	568,084.7x
Bv Per Share	0.55
CAPEX	$-31,000
Ch1m	115.5
Ch1w	4.32
Ch1y	1,110.4
Ch3m	60.11
Ch6m	66.5
Change	7.89%
Change From Open	7.32
Close	124.5
Days Gap	0.54
Depreciation Amortization	2,483,000
Dollar Volume	53,488,631.2
Earnings Date	2026-05-15
Earnings Time	amc
EBIT	$-135M
EBITDA	$-132.5M
EPS	$-9.04
F Score	3
FCF	$-129.8M
FCF EV Yield	-6.67x
FCF Per Share	$-8.89
Financing CF	101,446,000
Fiscal Year End	December
Founded	2,010
Income Tax	$2,000
Investing CF	-28,000
Ipr	690.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2024-02-28
Ma150	76.93
Ma150ch	74.65%
Ma20	112.4
Ma20ch	19.54%
Net CF	-28,376,000
Next Earnings Date	2026-05-22
Open	125.2
Optionable	Yes
Position In Range	95.78
Post Close	134.4
Postmarket Change Percent	9.59
Postmarket Price	$147
Ppne	9,268,000
Price Date	2026-05-08
Ptbv Ratio	245.5
Relative Volume	0.7x
Revenue	1,300,000x
SBC By Revenue	856.77x
Share Based Comp	11,138,000
Tax By Revenue	0.15x
Tr6m	66.5%
Us State	California
Volume	398,129
Z Score	-2.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INBX pay a dividend?

Capital-return profile for this ticker.

Performance

INBX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INBX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+61.2%

Float: +53.4% of shares outstanding

Insider ownership

+18.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INBX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.1

Neutral momentum band

Price vs 200-day MA

+109.1%

50/200-day relationship not available

Beta (5Y)

3.89

More volatile than the market

Sharpe ratio

2.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INBX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INBX stock rating?

Inhibrx Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INBX analysis?

The full report lives at /stocks/INBX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INBX?

The latest report frames INBX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INBX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.